Zur Zeit liegt uns keine Inhaltsangabe vor.
Inhaltsverzeichnis
Section 1: Adenosine Receptors and Effector Systems. - 1 Adenosine Agonists and Antagonists. - 2 Intracellular and Extracellular Metabolism of Adenosine and Adenine Nucleotides. - 3 Adenosine Deaminase and Adenosine Transport Systems in the CNS. - 4 Transport Systems for Adenosine in Mammalian Cell Membranes. - 5 Formation of Adenosine in the Heart from Extracellular Adenine Nucleotides. - 6 Central Nervous System Effects of Adenosine. - 7 Adenosine Receptor Sub-types in Isolated Tissues: Antagonist Studies. - 8 Molecular Probes for Adenosine Receptors. - 9 Purification of A1 Adenosine Receptor of Rat Brain Membranes by Affinity Chromatography. - 10 Characteristics of A1 Adenosine Receptors and Guanine Nucleotide Binding Proteins Co-Purified from Bovine Brain. - 11 Antagonist Radioligand Binding to Solubilized Porcine Atrial A1 Adenosine Receptors. - 12 Isolation of an Adenosine Binding Protein Which Has Properties Expected of the A1 Adenosine Receptor. - 13 Identification of the A2 Adenosine Receptor Binding Subunit by Photoaffinity Crosslinking. - 14 Human Placental Adenosine A2-Like Binding Sites Properties and Homology with Mammalian and Avian Stress Proteins. - 15 Cardiac Interstitial Fluid Adenosine in Normoxia and Hypoxia. - 16 Rationale for the Use of Adenosine in the Diagnosis and Treatment of Cardiac Arrhythmias. - 17 The Central Adenosine System as a Therapeutic Target in Stroke. - 18 Adenosine-Mediated Vasoconstriction in the Skin Microcirculation. - 19 Adenosine is an Antiinflammatory Autocoid: Adenosine Receptor Occupancy Promotes Neutrophil Chemotaxis and Inhibits Superoxide Anion Generation. - 20 Beta Adrenergic Receptor Mediated Stimulation of Adenine Nucleotide Catabolism and Purine Release in Human Adipocytes. - 21 Structure Activity Relationships for Adenosine Antagonists. - 22 Structure Activity Relationships for Adenosine Agonists. - 23 The Design of a Series of Highly A2 Selective Adenosine Agonists. - 24 Adenosine Agonists. Characterization of the N6-Subregion of the Adenosine A2 Receptor via Molecular Modeling Techniques. - 25 Physiological and Biochemical Aspects of P -Site-Mediated Inhibition of Adenylyl Cyclase. - 26 Adenosine Receptors Mediating Inhibition of Peripheral and Central Neurons. - 27 Adenosine Receptors as Drug Targets: Fulfilling the Promise? . - 28 Mechanisms of Adenosine Action. - 29 Functional Roles of A1 and A2 Receptors in Rat Hippocampus and Striatum. - 30 Subclassification of Neuronal Adenosine Receptors. - 31 Effects of Adenosine on Mast Cells. - 32 The Role of Adenosine on the Gastric Acid Secretory Response. - 33 Adenosine Receptors and Signaling in the Kidney. - 34 Inhibition of the Function of Guanine Nucleotide Binding Proteins by the New Positive Inotropes. - 35 Blockade of Antigen Activated Signals by Xanthine Analogs in RBL-2H3 Cells:Evidence for a Novel Adenosine Receptor. - Section 2: Adenine Nucleotide Receptors and Effector Systems. - 36 Classification and Characterization of Purinoceptors. - 37 Structure Activity Relationships for Adenine Nucleotide Receptors on Mast Cells, Human Platelets, and Smooth Muscle. - 38 Modulation of Norepinephrine Release by ATP and Adenosine. - 39 The Phospholipase C Linked P2y-Purinergic Receptor. - 40 Roles of an ADP Receptor on the Platelet Surface in Mediating Aggregation and Fibrinogen Binding. - Section 3: Phosphodiesterase Enzymes and Inhibitors. - 41 Structural and Functional Characterization of Cyclic GMP-Stimulated Phosphodiesterases and Their Role in Intracellular Signal Transduction. - 42 Phosphodiesterase Genes from Flies to Mammals. - 43 Structure and Function of theHigh Affinity, Rolipram and RO 2-1724 Sensitive, cAMP Phosphodiesterases. - 44 Correlation of 3H-Rolipram Binding to a Cerebral cAMP Phosphodiesterase with Antidepressant Activity. - 45 Mechanism for Dual Regulation of the Particulate cGMP-Inhibited cAMP Phosphodiesterase in Rat Adipocytes by Isoproterenol and Insulin. - 46 Expression of Calmodulin-Dependent Cyclic Nucleotide Phosphodiesterase in Developing and Adult Rat Brain. - 47 Regulation of cAMP Metabolism in PC12 Cells by Type II (cGMP-Activatable) Cyclic Nucleotide Phosphodiesterase. - 48 cGMP-Binding Phosphodiesterase: Novel Effects of cGMP Binding on the Interaction Between Functional Domains in the Enzyme. - 49 Clinical Investigations with Phosphodiesterase Inhibitors. - 50 Chemical Probes of Type IV Phosphodiesterase: Design, Synthesis, and Characterization of (3H)-2Y186126 as a Radioligand for Sites Within Cardiac Membranes. - 51 Purification of a cGMP-inhibited cAMP Phosphodiesterase from Vascular Smooth Muscle. - 52 Low KmcAMP Phosphodiesterase Isozymes and Modulation of Tone in Vascular, Airway and Gastrointestinal Smooth Muscle. - 53 Structure Activity Relationships of Xanthines as Inhibitors of Cyclic Nucleotide Phosphodiesterases and as Antagonists of Adenosine Receptors. - 54 Mechanisms of Xanthine Actions in Models of Asthma. - Section 4: Abstracts. - A Intracellular and Extracellular Metabolism of Adenosine and Adenine Nucleotides. - B Molecular Probes for Purinoceptors. - C Phosphodiesterases - Multiples Forms and Regulation. - D The Physiological Effects of Adenosine and Adenine Nucleotides. - E Structure Activity Relationships at Adenosine and ATP Receptors. - F Effector Systems for Modulation of Biological Response by Purines. - G Phosphodiesterase Inhibitors - Mechanisms and Structure Activity Relationships. - Author Index.